Formoterol

  • 1 lab in 1 country
  • 1 trial, none about aging
  • Funders: National Natural Science Foundation of China and 2 more
  • Animals1

Outcomes

2

SIRT1

upin mice1

1 study
  1. Formoterol increases SIRT1 in mice.

    “expression of sirtuin 1 (SIRT1) in aorta is decreased in EPO-induced AAA but remarkably elevated by medium-dose formoterol.”

    Animalsin aorta of EPO-induced AAA micemedium-dose

    Medium-Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Feb 14, 2024

More on SIRT1

Cellular senescence

downin mice1

1 study
  1. Formoterol decreases cellular senescence in mice.

    “senescence of vascular smooth muscle cell (VSMC) is increased by EPO while decreased by medium-dose formoterol both in vivo and in vitro”

    Animalsin EPO-treated VSMCs in vivo and in vitromedium-dose

    Medium-Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Feb 14, 2024

More on Cellular senescence

Associations

1

Abdominal aortic aneurysm

downin mice1

1 study
  1. Formoterol lowers the risk of abdominal aortic aneurysm in mice (10% vs 55%).

    “The incidence of AAA is 0, 55%, 35%,10%, and 55% in these 5 groups, respectively.”

    Animalsin ApoE-/- mice treated with EPOmedium-dose

    Medium-Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Feb 14, 2024

More on Abdominal aortic aneurysm

Trial sponsors

Latest